Category: Prescription Drugs
Global Prescription Drugs
-
Sexual & Reproductive Health Drugs Market by Drugs Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Global Forecast 2024-2030
... Reproductive Health Drugs Market size was estimated at USD 31.64 billion in 2023 and expected to reach USD 35.83 billion in 2024, at a CAGR 13.34% to reach USD 76.03 billion by 2030. Global Sexual ... Read More
-
Analgesics Market by Drug Type (Acetaminophen, Nonsteroidal Anti-Inflammatory Drugs, Salicylates), Type (Non-Opioids, Opioids), Route of Administration, Distribution - Global Forecast 2024-2030
... to reach USD 23.75 billion in 2024, at a CAGR 8.79% to reach USD 39.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Analgesics Market. It offers a ... Read More
-
Rheumatology Therapeutics Market by Indication (Ankylosing Spondylitis, Gout, Osteoarthritis), Distribution Channel (Offline Mode, Online Stores) - Global Forecast 2024-2030
... reach USD 33.24 billion in 2024, at a CAGR 6.51% to reach USD 48.58 billion by 2030. Global Rheumatology Therapeutics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Rheumatology Therapeutics ... Read More
-
Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration, End-User - Global Forecast 2024-2030
... expected to reach USD 145.40 million in 2024, at a CAGR 5.66% to reach USD 203.54 million by 2030. Global Pleurodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Vulvodynia Treatment Market by Type (Biofeedback & Physical Therapy, Intralesional Injections, Oral Treatment), Indication (Generalized Vulvodynia, Localized Vulvodynia), Providers - Global Forecast 2024-2030
... 2023 and expected to reach USD 60.82 billion in 2024, at a CAGR 9.62% to reach USD 105.67 billion by 2030. Global Vulvodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Diuretics Drugs Market by Drug Type (Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics), Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies), Route of Administration, Applications - Global Forecast 2024-2030
... was estimated at USD 1.19 billion in 2023 and expected to reach USD 1.29 billion in 2024, at a CAGR 8.54% to reach USD 2.12 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Muscle Relaxants Drug Market by Drug (Facial Muscle Relaxant, Neuromuscular Relaxant, Skeletal Muscle Relaxant), Distribution (Clinics, Drug Stores, Hospitals) - Global Forecast 2024-2030
... in 2023 and expected to reach USD 4.78 billion in 2024, at a CAGR 7.88% to reach USD 7.55 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Muscle ... Read More
-
Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030
... expected to reach USD 1,026.86 million in 2024, at a CAGR 8.74% to reach USD 1,705.58 million by 2030. Global Postpartum Depression Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030
... and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030. Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method ... Read More
-
Cold Pain Therapy Market by Product (OTC Products, Prescription Products), Distribution Channel (E-commerce, Hospital Pharmacy, Retail Pharmacy), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 2.22 billion in 2024, at a CAGR 8.20% to reach USD 3.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Cold Pain ... Read More
-
Anti-Obesity Drugs Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Mechanism of Action (Centrally Acting Drugs, Peripherally Acting Drugs) - Global Forecast 2024-2030
... 2023 and expected to reach USD 4.09 billion in 2024, at a CAGR 6.86% to reach USD 6.10 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Drugs ... Read More
-
Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030. Global Women's Health MarketThe women's health market includes diagnosis, treatments, medications, surgical procedures, and ... Read More
-
Anti-obesity Prescription Drugs Market by Drug Class (Bupropion & Naltrexone, Liraglutide, Lorcaserin), Age Group (Adult, Pediatric), Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 6.71 billion in 2024, at a CAGR 8.12% to reach USD 10.74 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-obesity Prescription ... Read More
-
Anti-Obesity Therapeutics Market by Treatment Type (Medications, Treatments), End-use (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2024-2030
... reach USD 10.81 billion in 2024, at a CAGR 8.44% to reach USD 17.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anti-Obesity Therapeutics Market. It offers a ... Read More
-
Antipsychotic Drugs Market by Class (First Generation, Second Generation, Third Generation), Indication (Bipolar Disorders, Dementia, Schizophrenia) - Global Forecast 2024-2030
... to reach USD 10.42 billion in 2024, at a CAGR 8.01% to reach USD 16.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antipsychotic Drugs Market. It offers ... Read More
-
Digital Pharmacy Market by Drug Type (Over-The-Counter Drugs, Prescription Drugs), Platform (Apps, Websites) - Global Forecast 2024-2030
... 164.91 billion in 2024, at a CAGR 19.20% to reach USD 475.08 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital Pharmacy Market. It offers a comprehensive assessment ... Read More
-
Long-acting Contraception Market by Type (Long-Acting Contraceptives, Short-Acting Contraceptives), Product (Injectables, Intrauterine Devices, Subdermal Implants), Application, End-use - Global Forecast 2024-2030
... expected to reach USD 3.68 billion in 2024, at a CAGR 7.06% to reach USD 5.52 billion by 2030. Global Long-acting Contraception Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2024-2030
... reach USD 3.07 billion in 2024, at a CAGR 5.67% to reach USD 4.30 billion by 2030. Global Insomnia Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Insomnia Drugs ... Read More
-
Insomnia Pharmacological Treatment Market by Drug (OTC Drugs, OTC Sleep Aids, OTC Sleep Supplements), Treatment (Over-the-Counter Sleep Aids, Prescription Sleep Aids), Distribution Channel - Global Forecast 2024-2030
... at USD 6.58 billion in 2023 and expected to reach USD 7.01 billion in 2024, at a CAGR 7.07% to reach USD 10.62 billion by 2030. Global Insomnia Pharmacological Treatment Market FPNV Positioning Matrix The ... Read More
-
Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2024-2030
... expected to reach USD 18.34 billion in 2024, at a CAGR 6.76% to reach USD 27.19 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Hormonal Contraceptives Market. It ... Read More
-
Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Global Forecast 2024-2030
... USD 8.28 billion in 2023 and expected to reach USD 10.18 billion in 2024, at a CAGR 24.18% to reach USD 37.71 billion by 2030. Global Smart Drugs & Pills MarketSmart drugs & pills equipped ... Read More
-
Vision Care Market by Product (Cleaning & Disinfecting Solutions, Contact Lenses, Spectacle Lenses), Type (Non-Rx (Non-Prescription), Rx (Prescription)), Distribution Channel - Global Forecast 2024-2030
... in 2023 and expected to reach USD 84.71 billion in 2024, at a CAGR 8.19% to reach USD 136.37 billion by 2030. Global Vision Care Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Calcium Gluconate Market by Form (Liquid, Powder), End-User (Food & Beverage, Personal Care, Pharmaceuticals) - Global Forecast 2024-2030
... USD 817.22 million in 2024, at a CAGR 5.54% to reach USD 1,132.92 million by 2030. Global Calcium Gluconate Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Calcium Gluconate Market. ... Read More
-
Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Global Forecast 2024-2030
... 9.32 billion in 2023 and expected to reach USD 9.91 billion in 2024, at a CAGR 6.41% to reach USD 14.40 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Fertility Supplements Market by Ingredient Type (Arginine, Coenzyme Q10 (CoQ10), Folic Acid), Source (Natural/Herbal, Synthetic), Dosage Form, Prescription, End-Use, Distribution Channel - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 2.30 billion in 2024, at a CAGR 7.63% to reach USD 3.58 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
Research Assistance
